G01N 2333/952
Derived from bacteria
Official title: derived from bacteria
G01N2333/952 (Derived from bacteria) appears on 99 US grants and 146 published applications in this corpus.
Search patents in G01N- Granted patents
- 99
- Published applications
- 146
- Assignees
- 88
- Inventors
- 225
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 3 |
| 2011 | 1 | 1 |
| 2012 | 2 | 7 |
| 2013 | 3 | 5 |
| 2014 | 3 | 7 |
| 2015 | 6 | 22 |
| 2016 | 9 | 18 |
| 2017 | 7 | 16 |
| 2018 | 11 | 10 |
| 2019 | 14 | 10 |
| 2020 | 11 | 7 |
| 2021 | 5 | 10 |
| 2022 | 5 | 10 |
| 2023 | 5 | 4 |
| 2024 | 6 | 5 |
| 2025 | 8 | 5 |
| 2026 | 3 | 5 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for the detection of Clostridium neurotoxins using a chimeric substrate fusion protein22 Sep 2026US 12,742,784 B2Prime Bio, Inc.
- Engineered botulinum neurotoxin17 Mar 2026US 12,577,550 B2President and Fellows of Harvard College
- Protease and binding polypeptide for O-glycoproteins20 Jan 2026US 12,529,044 B2Genovis AB
- Antibodies for botulinum neurotoxins21 Oct 2025US 12,448,463 B2The Regents of the University of California
- Enzymes for glycan analysis21 Oct 2025US 12,448,614 B2Genovis AB
- Assay for Rapid Detection of Antibiotic Resistant Organisms8 Oct 2026US 2026/0308658 A1Queen's University at Kingston
- Methods of determining relative unpaired glycan content1 Oct 2026US 2026/0298943 A1Amgen Inc.
- Cells sensitive to botulinum toxin into which specific gene has been inserted by lentivirus13 Aug 2026US 2026/0234692 A1Atgc Inc.
- Novel fluorescent compound, and composition for detecting gingipain, composition for diagnosing porphyromonas gingivalis infection, or antibacterial composition against porphyromonas gingivalis using same30 Jul 2026US 2026/0219277 A1Korea Institute of Science and Technology
- Vhh polypeptides that bind to light chain (lc) proteases of botulinum neurotoxins (bonts) and methods of use thereof2 Jul 2026US 2026/0184813 A1Trustees of Tufts College
Most cited
By later US patents
- Protein sequencing method and reagents65US 9,566,335 B1The Governing Council of the University of Toronto · 2017
- Protein sequencing method and reagents40US 10,481,162 B2The Governing Council of the University of Toronto · 2019
- Immuno-based botulinum toxin serotype A activity assays39US 8,198,034 B2Allergan, Inc. · 2012
- Immuno-based botulinum toxin serotype A activity assays27US 8,618,261 B2Allergan, Inc. · 2013
- Methods and compounds for increasing sensitivity of botulinum assays25US 9,303,285 B2BioMadison, Inc. · 2016